PSEUDOHYPOPYON

PSEUDOHYPOPYON was reported 12 times

PSEUDOHYPOPYON is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 3 0.0000
1 Glycopeptide Antibacterial [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Corticosteroid [EPC] 7 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000